trend
GLP-1 Users Prioritize Walking Over Strength Training, New Data Shows
New tracking data from companion app MeAgain shows walking is the primary workout for patients taking semaglutide and tirzepatide, beating out strength training and Pilates. While daily step counts stay high, skipping resistance training worsens the lean mass loss common on appetite suppressants. It leaves users lighter on the bathroom scale but metabolically vulnerable over time.
New tracking data from companion app MeAgain shows walking is the primary workout for patients taking semaglutide and tirzepatide, beating out strength training and Pilates. While daily step counts stay high, skipping resistance training worsens the lean mass loss common on appetite suppressants. It leaves users lighter on the bathroom scale but metabolically vulnerable over time.
The architecture take
I get why people on tirzepatide head straight for a morning walk instead of a squat rack. When your caloric intake drops by 40% and nausea hits on shot day, lacing up sneakers for a thirty-minute stroll feels like the only gentle, non-punishing option. I used to think any movement was a win during rapid weight loss. I was wrong. When you drop weight fast on a GLP-1 agonist, up to 40% of the pounds shed can come from skeletal muscle rather than fat. Walking supports cardiovascular baseline and keeps resting glucose steady, but it does almost nothing to signal muscle protein synthesis. Without resistance work, your resting metabolic rate dives, and you lose the primary tissue responsible for clearing blood sugar. Gyms like Equinox and Life Time are already scrambling to build GLP-1 resistance programs because they see the crisis coming. If you are taking the injection, pick up two heavy dumbbells twice a week before you log another five miles.